SUSAN MAYNE: Open Payments
NPI 1114474368 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 13 payments from 7 companies in 2025. Trend: 2023 $759 · 2024 $436 · 2025 $453
Food & beverage: $368Education: $85
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $165 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $104 |
| Lilly USA, LLC | 1 | $81 |
| GENZYME CORPORATION | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Organon LLC | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $17 |
Products named: Bimzelx, EBGLYSS, DUPIXENT, Rhapsido, VTAMA, ILUMYA, NEMLUVIO.
Industry payments across OH — which companies pay providers there.
